Clinical Trials Logo

Clinical Trial Summary

Conventionally, a relatively high level of fraction of inspired oxygen (FiO2) has been used for secure a margin of safety in patients undergoing cardiac surgery using cardiopulmonary bypass (CPB). Since the potential adverse effects of hyperoxemia (via reactive oxygen species, vasocontriction, perfusion heterogeneity, myocardiac injury, etc.), various studies on this topic has been performed. However, the results are conflicting and inconsistent, and the consensus about whether the use of additional oxygen supply in cardiac surgery using CPB has not been reached among practitioners yet.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Patients Undergoing Cardiac Surgery Using Cardiopulmonary Bypass

NCT number NCT03939832
Study type Interventional
Source Seoul National University Hospital
Contact
Status Withdrawn
Phase N/A
Start date November 2021
Completion date December 2022